Details

Autor(en) / Beteiligte

• Minta, Anna A
• Ferrari, Matt
• Antoni, Sebastien
• Portnoy, Allison
• Sbarra, Alyssa
• Lambert, Brian
• Hatcher, Cynthia
• Hsu, Christopher H
• Ho, Lee Lee
• Steulet, Claudia
• Gacic-Dobo, Marta
• Rota, Paul A
• Mulders, Mick N
• Bose, Anindya Sekhar
• Caro, William Perea
• O'Connor, Patrick
• Crowcroft, Natasha S

Titel

Progress Toward Measles Elimination — Worldwide, 2000–2022

Ist Teil von

• MMWR. Morbidity and mortality weekly report, 2023-11, Vol.72 (46), p.1262-1268

Ort / Verlag

Atlanta: U.S. Government Printing Office

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no region has achieved and sustained measles elimination. This report describes measles elimination progress during 2000-2022. During 2000-2019, estimated coverage worldwide with the first dose of measles-containing vaccine (MCV) increased from 72% to 86%, then declined to 81% in 2021 during the COVID-19 pandemic, representing the lowest coverage since 2008. In 2022, first-dose MCV coverage increased to 83%. Only one half (72) of 144 countries reporting measles cases achieved the measles surveillance indicator target of two or more discarded cases per 100,000 population in 2022. During 2021-2022, estimated measles cases increased 18%, from 7,802,000 to 9,232,300, and the number of countries experiencing large or disruptive outbreaks increased from 22 to 37. Estimated measles deaths increased 43% during 2021-2022, from 95,000 to 136,200. Nonetheless, an estimated 57 million measles deaths were averted by vaccination during 2000-2022. In 2022, measles vaccination coverage and global surveillance showed some recovery from the COVID-19 pandemic setbacks; however, coverage declined in low-income countries, and globally, years of suboptimal immunization coverage left millions of children unprotected. Urgent reversal of coverage setbacks experienced during the COVID-19 pandemic can be accomplished by renewing efforts to vaccinate all children with 2 MCV doses and strengthening surveillance, thereby preventing outbreaks and accelerating progress toward measles elimination.